DK1328546T3 - Cyclopeptider, fremgangsmåde til deres fremstilling og deres anvendelse som angiogenese-inhibitorer eller -aktivatorer - Google Patents

Cyclopeptider, fremgangsmåde til deres fremstilling og deres anvendelse som angiogenese-inhibitorer eller -aktivatorer

Info

Publication number
DK1328546T3
DK1328546T3 DK01974427T DK01974427T DK1328546T3 DK 1328546 T3 DK1328546 T3 DK 1328546T3 DK 01974427 T DK01974427 T DK 01974427T DK 01974427 T DK01974427 T DK 01974427T DK 1328546 T3 DK1328546 T3 DK 1328546T3
Authority
DK
Denmark
Prior art keywords
cyclopeptides
activators
preparation
methods
angiogenesis inhibitors
Prior art date
Application number
DK01974427T
Other languages
Danish (da)
English (en)
Inventor
Natacha Betz
Andreas Bikfalvi
Gerard Deleris
Original Assignee
Commissariat Energie Atomique
Univ Victor Segalen Bordeaux 2
Univ Bordeaux 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Univ Victor Segalen Bordeaux 2, Univ Bordeaux 1 filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of DK1328546T3 publication Critical patent/DK1328546T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK01974427T 2000-10-04 2001-10-02 Cyclopeptider, fremgangsmåde til deres fremstilling og deres anvendelse som angiogenese-inhibitorer eller -aktivatorer DK1328546T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012654A FR2814744B1 (fr) 2000-10-04 2000-10-04 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
PCT/FR2001/003049 WO2002028895A2 (fr) 2000-10-04 2001-10-02 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese

Publications (1)

Publication Number Publication Date
DK1328546T3 true DK1328546T3 (da) 2007-06-04

Family

ID=8854977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01974427T DK1328546T3 (da) 2000-10-04 2001-10-02 Cyclopeptider, fremgangsmåde til deres fremstilling og deres anvendelse som angiogenese-inhibitorer eller -aktivatorer

Country Status (15)

Country Link
US (2) US7199100B2 (no)
EP (1) EP1328546B1 (no)
JP (1) JP4303958B2 (no)
AT (1) ATE354589T1 (no)
AU (2) AU2001293948B2 (no)
CA (1) CA2424506A1 (no)
DE (1) DE60126802T2 (no)
DK (1) DK1328546T3 (no)
ES (1) ES2282293T3 (no)
FR (1) FR2814744B1 (no)
IL (1) IL155117A0 (no)
NO (1) NO20031377L (no)
NZ (1) NZ525069A (no)
RU (1) RU2249599C2 (no)
WO (1) WO2002028895A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003278807A1 (en) * 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) * 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
ES2396368T3 (es) 2003-03-03 2013-02-21 Dyax Corporation Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
BRPI0706400A2 (pt) * 2006-01-17 2011-03-29 Organon Nv processos para a hidrólise enzimática seletiva de terc-butil ésteres c-terminais de substratos de peptìdeo, para a sìntese convergente de um peptìdeo de dois ou mais fragmentos de peptìdeo, para a sìntese enzimática por etapas de um peptìdeo na direção do terminal c, e para a sìntese de peptìdeo
JP5186632B2 (ja) 2006-10-19 2013-04-17 ブリッタ ハーディ， 血管形成を誘導するための組成物および方法
US8741850B2 (en) * 2009-07-24 2014-06-03 Advanced Accelerator Applications S.A. Compounds modulators of VEGF activity and uses thereof
FR2969999B1 (fr) 2011-01-03 2013-02-08 Commissariat Energie Atomique Conjugue, son procede de preparation et ses utilisations
WO2014034922A1 (ja) * 2012-09-03 2014-03-06 国立大学法人東京大学 血管内皮細胞増殖因子受容体阻害ペプチド
CN103724290B (zh) * 2013-11-15 2015-04-29 浙江大学 一种环肽化合物clavatustide A及其产生菌、制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4237456A1 (de) * 1992-11-06 1994-05-11 Merck Patent Gmbh Cyclopeptide
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5939383A (en) * 1996-11-15 1999-08-17 Remacle; Jose Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same
CA2320339A1 (en) * 1998-02-11 1999-08-19 Resolution Pharmaceuticals Inc. Angiogenesis targeting molecules
KR20010102556A (ko) * 1999-03-11 2001-11-15 추후제출 암 및 과증식성 장애의 치료 조성물 및 치료방법

Also Published As

Publication number Publication date
EP1328546B1 (fr) 2007-02-21
JP2004510784A (ja) 2004-04-08
US7199100B2 (en) 2007-04-03
USRE44022E1 (en) 2013-02-19
ATE354589T1 (de) 2007-03-15
US20040092434A1 (en) 2004-05-13
DE60126802T2 (de) 2007-11-08
DE60126802D1 (de) 2007-04-05
ES2282293T3 (es) 2007-10-16
JP4303958B2 (ja) 2009-07-29
NO20031377D0 (no) 2003-03-26
AU2001293948B2 (en) 2005-11-03
EP1328546A2 (fr) 2003-07-23
RU2249599C2 (ru) 2005-04-10
FR2814744B1 (fr) 2002-11-29
AU9394801A (en) 2002-04-15
FR2814744A1 (fr) 2002-04-05
IL155117A0 (en) 2003-10-31
WO2002028895A3 (fr) 2002-06-06
NO20031377L (no) 2003-05-02
CA2424506A1 (en) 2002-04-11
WO2002028895A2 (fr) 2002-04-11
NZ525069A (en) 2004-09-24

Similar Documents

Publication Publication Date Title
DK1328546T3 (da) Cyclopeptider, fremgangsmåde til deres fremstilling og deres anvendelse som angiogenese-inhibitorer eller -aktivatorer
NO20020348D0 (no) Peptid acceptor ligeringsmetoder
WO2001077951A8 (en) System and methods for group retirement plan administration
DK0698105T3 (da) Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle
EE05485B1 (et) Plasmi(i)n(ogeen)i eemaldamine valgulahustest
CO5590973A2 (es) Acido nucleico de adenovirus de simio y secuiencias de aminoacidos, vectores que contienen los mismos y metodos de uso
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
DE60142646D1 (en) Fusionprotein
WO2003012114A3 (en) Methods of rna and protein synthesis
PT1165115E (pt) Modulacao da permeabilidade vascular por meio dos activadores do receptor tie2
PT1024822E (pt) Cd8 como inibidor do sistema imunitario celular
NO942110L (no) Lipopeptider fra Actinoplanes sp. med farmakologisk virkning fremgangsmåte for fremstilling og anvendelse derav
DK1792982T3 (da) Codon-optimeret phosphatase og ekspression heraf i gær
NO974035L (no) En ny vekstfaktor og en genetisk sekvens som koder for denne
IL127297A0 (en) Spruce budworm antifreeze proteins genes and methods of using same
AU8198001A (en) Dermal for amino laevulinic acid
NO981748L (no) Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette
DK0918865T3 (da) Immunologisk aktive proteiner af Borrelia burgdorferi, derfor kodende nukleinsyrer samt deres anvendelse i testkits og som vacciner
DK1097233T3 (da) Promotor for vækstdifferentieringsfaktor og anvendelser deraf
NO20055210L (no) Inhibitorproteiner av en protease og anvendelse derav
TR200100430T2 (tr) Tyrosine kinase SRC kullanılan angiogenesisin modülasyonu için yararlı metot ve bileşimler.
DE69823188D1 (de) Klonierung der udp-galaktose-epimerase
ATE401408T1 (de) Tapetum-spezifische promotoren
DK0895537T3 (da) IGA1 proteasefragment som bærerpeptid
AU5617301A (en) Aspartate carbamyltransferase as herbicidal target